Throughout the year, our Editors may issue a Call for Papers for a special collection of articles for a themed issue or themed section of the journal. Below you’ll find links to the current Call for Papers for Value in Health.
Call for Papers:
Evidence Synthesis in Health Economics and Outcomes Research
Evidence synthesis—including systematic reviews with narrative, qualitative, and/or quantitative synthesis—is an important set of approaches to summarizing multiple sources of evidence, as well as identifying methods and evidence gaps in the field of health economics and outcomes research (HEOR). Evidence synthesis provides a strong foundation for the development of evidence-informed best practice recommendations and new methods and applications. Evidence synthesis and meta-analyses are also important ways of obtaining data inputs for economic models used to assess the value of health technologies.
Recognizing the inherent usefulness of evidence synthesis, the Editors of Value in Health are issuing an open Call for Papers reporting evidence synthesis on a wide array of topics in HEOR that seek to inform healthcare decision making. Papers on evidence synthesis are welcome on any topic in HEOR that lies within the aims and scope of Value in Health. Studies can address any aspect of the methods and evidence used to assess the value of healthcare, but papers reporting reviews of studies containing only clinical endpoints are out of scope for this call.
Authors should submit manuscripts through the journal's online submission system at https://mc.manuscriptcentral.com/valueinhealth. Also, be sure to indicate in your cover letter that the paper is to be considered as a systematic review.
Measuring Change in Rare Disease Outcomes: Implications From Patient-Focused Drug Development Guidance
Interpreting within-subject meaningful change in rare disease outcomes requires innovative qualitative and quantitative mixed methodological approaches due to heterogeneity among patients and limited same size. This themed section will focus on innovative methodologies and research designs focused on evaluation of meaningful change in rare disease, specifically considering the Patient Focused Drug Development guidance and the 2009 FDA Guidance for Industry Patient Reported Outcomes.
The Editors are looking for submissions that present multiple research designs (ie, qualitative, quantitative, and mixed methods analytic techniques) with accompanying data visualization approaches for deriving, analyzing, and communicating meaningful change in rare disease with a focus on alignment with regulatory Patient Focused Drug Development guidance.
Authors should submit manuscripts through the journal's online submission system at https://mc.manuscriptcentral.com/valueinhealth before April 30, 2025. Also, be sure to indicate in your cover letter that the paper is to be considered as part of the Measuring Change in Rare Disease Outcomes theme.
Digital Health Technologies: Examining Value, Regulation, and Equity
Value in Health invites submissions for a thematic issue dedicated to exploring the nuanced landscape of health preference research and value assessment frameworks in the realm of digital health technologies. This special collection of papers aims to dissect the complex interplay between technological innovation, health economics, and policy making in the context of rapidly evolving digital health applications.
The Editors are looking for papers that shed light on the evolving paradigms in digital health valuation and offer insights that shape the future of healthcare technology assessment and policy.
Authors should submit manuscripts through the journal's online submission system at https://mc.manuscriptcentral.com/valueinhealth before May 15, 2025. Also, be sure to indicate in your cover letter that the paper is to be considered as part of the Digital Health Technologies theme.
Contribute to Value in Health
- Submit a manuscript/revision
- Become a peer reviewer
- Check manuscript status